Exercise Is the Best Longevity Drug We Have
No pill matches the mortality data behind cardiorespiratory fitness. Here is what the evidence says about VO2 max, zone 2 and how much exercise is enough.
If a pharmaceutical company invented a drug with the mortality data that exercise has, it would be the most valuable molecule in history. The relationship between cardiorespiratory fitness and the risk of dying is one of the strongest, most consistent findings in all of preventive medicine. It is dose-dependent, it holds across populations, and it dwarfs the effect sizes of most things sold in a bottle. The catch is that you cannot swallow it. You have to do it. This is the honest, slightly inconvenient core of “exercise is medicine,” and the science behind it is worth understanding properly rather than as a slogan.
VO2 max and the mortality curve
The headline metric is VO2 max, the maximum rate at which your body can take in and use oxygen. It is the single best laboratory measure of aerobic fitness, and it tracks closely with how long people live. A large 2018 study from the Cleveland Clinic, published in JAMA Network Open, followed more than 122,000 people who underwent treadmill testing. The finding was blunt: higher fitness was associated with lower mortality, with no observed upper limit of benefit. The least-fit group had a risk of death several times higher than the elite-fitness group.
The size of the effect is what makes researchers reach for superlatives. In that analysis, being in the lowest fitness category carried a mortality risk comparable to, and in some comparisons worse than, established conditions like coronary disease, diabetes or smoking. The comparison is imperfect because fitness is partly a marker of underlying health, not only a cause of it. But the consistency across decades of cohort studies makes a strong case that improving fitness genuinely moves the needle, especially for people starting from the bottom.
The dose-response, and where it bends
How much exercise do you need? The reassuring news is that the curve is steepest at the start. Going from doing nothing to doing a little produces the biggest single drop in mortality risk. Public-health guidelines from the World Health Organization and the US Physical Activity Guidelines converge on roughly 150 to 300 minutes of moderate activity per week, plus two sessions of strength work. Meeting that target is associated with meaningfully lower risk of cardiovascular disease, several cancers and early death.
More appears to be better, up to a point, with diminishing returns rather than a sharp reversal at high volumes. Worries that extreme endurance exercise might harm the heart apply, if at all, to a small minority at the very far end, and should not discourage anyone in the normal range. For nearly everyone, the practical message is that the first 20 minutes a day matters most, and the gap between “sedentary” and “somewhat active” is the most valuable distance you will ever cover.
Zone 2: the base of the pyramid
Among longevity-minded athletes and physicians, the most fashionable training concept is zone 2, low-intensity aerobic work performed at an effort you could sustain while holding a conversation. The physiological rationale, popularized by the exercise physiologist Iñigo San Millán, who has worked with Tour de France cyclists, is that this intensity preferentially trains the mitochondria and improves the body’s ability to burn fat and clear lactate. Mitochondrial function declines with age and is impaired in metabolic disease, which is why San Millán frames zone 2 as both performance work and metabolic health work.
The physician Peter Attia built much of his public training framework around this idea, recommending several hours a week of zone 2 alongside dedicated VO2-max intervals and strength training. The logic is sound and the underlying mitochondrial biology is real. Where honesty is required is in the specifics: the precise heart-rate boundaries of “zone 2” are fuzzy and individual, and there is no controlled trial proving that zone 2 specifically beats other equally-matched training for longevity. What is well established is that a large base of easy aerobic work plus some hard intervals is an effective, sustainable way to raise VO2 max. The branding is newer than the science.
Separating the proven from the promising
It helps to sort the claims by how solid they are. Firmly established: cardiorespiratory fitness strongly predicts mortality, exercise improves it, and meeting basic activity guidelines lowers risk of death and major disease. Well supported: VO2-max intervals and easy aerobic base training both raise fitness, and resistance training independently lowers mortality, a point we develop in muscle as a longevity organ.
More promising than proven: that one specific intensity zone is uniquely beneficial, that lactate thresholds must be precisely managed, and that consumer-grade VO2-max estimates from watches are accurate enough to train by. Those estimates can be off by a wide margin, so treat the number as a rough trend, not gospel. The risk in the longevity-exercise space is not that the core idea is wrong. It is that a solid foundation gets dressed up in unnecessary precision and gadgetry.
How to actually use this
The protocol that follows from the evidence is unglamorous and durable. Build a weekly base of easy aerobic activity, the conversational pace, across most days. Add one or two harder sessions that push toward your VO2-max ceiling, because that ceiling is what the mortality data cares about most. Strength-train at least twice a week. And above all, choose something you will still be doing in ten years, because adherence beats optimization every time.
The athletes who model this best, the ones who stayed elite into their late 30s and beyond, did not rely on exotic protocols. They trained their engines hard, rested deliberately, and kept showing up, the same pattern we trace in extending athletic careers. Exercise as medicine is not a metaphor. It is a prescription with overwhelming evidence and almost no side effects, and the only hard part is taking it.
FAQ
Is VO2 max really one of the best predictors of how long I will live? Yes. In large cohort studies, including the Cleveland Clinic analysis of more than 122,000 people, higher cardiorespiratory fitness was associated with substantially lower all-cause mortality, with no clear upper limit of benefit. Fitness is partly a marker of underlying health rather than purely a cause, so the effect is not entirely modifiable. But improving fitness, especially from a low baseline, is one of the highest-impact things a person can do.
Do I need to train in zone 2 specifically, or is that hype? Zone 2, easy aerobic work you could talk through, is a sound and sustainable way to build an aerobic base, and the mitochondrial science behind it is real. What is overhyped is the idea that it must be hit with surgical precision, or that it uniquely outperforms other matched training for longevity. A mix of plenty of easy aerobic work and some hard intervals raises VO2 max effectively. Do not let the branding intimidate you into inaction.
Sources
- Association of cardiorespiratory fitness with long-term mortality – JAMA Network Open (Cleveland Clinic)
- WHO guidelines on physical activity and sedentary behaviour – World Health Organization
- Physical Activity Guidelines for Americans, 2nd edition – US Department of Health and Human Services
- Metabolism of exercise and the role of zone 2 / lactate – Iñigo San Millán, Cell Metabolism
- Leisure-time physical activity and mortality: dose-response – JAMA Internal Medicine
- Importance of assessing cardiorespiratory fitness in clinical practice – Circulation (American Heart Association)
longevity exercise as medicine VO2 max zone 2 training all-cause mortality cardiorespiratory fitness Peter Attia Inigo San Millan